Major Shareholder Increases Stake in SH Pharma

Stock News06-12

SH Pharma (02607) has announced that on June 10, 2026, the company received a notification from its controlling shareholder, Shanghai Industrial Investment (Group) Co., Ltd. (referred to as "SIIC Group").

During the period from May 6, 2026, to June 10, 2026, SIIC Group, through its wholly-owned subsidiary SIIC International, accumulated an increased holding of 38.6 million H shares in the company.

Following this change in equity interest, Shanghai Industrial Investment (Group) Co., Ltd. now holds 1,484,975,837 shares of the company, representing 40.04% of the total issued share capital of 3,708,361,809 shares.

The change in equity was effected through secondary market block trades, with the funds for the share purchase sourced from its own capital.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment